Hims & Hers Health Inc - Class A Stock Prediction and Forecast [HIMS]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 04 Oct 2025, 03:37 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Hims & Hers Health Inc - Class A Stock Prediction and Forecast [HIMS]](https://i.ytimg.com/vi/lpp8mAbWvXg/hqdefault.jpg)
AI-generated source summary
The video provides an analysis of HIMS stock as of October 3rd, 2025. The analysis categorizes the stock as Hold/Accumulate, with a score of 0.743, since September 11th, 2025. The stock has typical fluctuations with a 1.51% gain resulting in an average daily gain of 0.09%. The 3 month trend indicates a potential change of 1.18% with possible returns between -19.48% and 28.51%. The stock operates within a wide horizontal trend. A 12-month analysis suggests a 65.01% change, varying between 31.43% and 187.26%, translating to a price between $69.06 and $150.92. On the last trading day the stock decreased 9.21% closing at $52.54. Weekly volatility is 6.18% categorized as high risk. The first resistance level is at $55.52, with support at $51.24. The price-to-earnings ratio is 60.89, and the earnings report is expected on November 3rd, 2025. Insider power is negative with a ratio of -47.891. The suggested stop-loss is $49.89, a 5.04% decline.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
